Searchable abstracts of presentations at key conferences in endocrinology

ea0017p15 | (1) | BSPED2008

BSPED audit of patient choice in GH therapy

Kirk J , Langham S

There is now evidence that patient choice in GH device not only improves adherence with GH therapy, but in addition is associated with improved height velocity (Kapoor et al. 2008). In order to find out how common free patient choice is for those commencing GH therapy, and how choice is provided, a questionnaire was sent to all members of the BSPED.A total of 38 questionnaires were received, including from 19 Health Services Human Growth Hormone C...

ea0017p33 | (1) | BSPED2008

Pseudohypoparathyroidism: an evolving clinical and biochemical picture

Joshi S , Cheetham T

Introduction: Children with pseudohypoparathyroidism (PHP) can have a broad range of phenotypic features and biochemical abnormalities. The heterogeneity of this patient group prompted us to review the clinical features of these children in our service.Methods: We recorded the mode of presentation, clinical features, growth pattern, biochemical profile and progress of 13 paediatric patients with PHP and hypocalcaemia under review in our service over a 11...

ea0012p74 | Pituitary | SFE2006

Anaemia: A rare presenting feature of pituitary tumour

Zachariah S , Rodin A

A 40 year old gentleman presented to his GP with a 12 month history of tiredness and breathlessness on playing basketball with his son. Initial investigations revealed he had a normocytic anaemia with haemoglobin of 9.8 and white cells and platelets were normal. He was referred to the Gastroenterologists and had normal renal function, liver function, bone profile, ESR and serum electrophoresis. His B12, folate and ferritin were normal. CT Abdomen was normal and duodenal biopsy...

ea0012p93 | Reproduction | SFE2006

Continuation rate and reasons of early removal of the levonorgestrel-releasing intrauterine system

Daud S , Ewies AAA

BackgroundThe levonorgestrel-releasing intrauterine system (LNG-IUS) is commonly used by gynaecologists and general practitioners as a contraceptive and to treat menorrhagia.ObjectiveTo identify the continuation rate and symptoms associated with early removal of the LNG-IUS before the 5 years effective life-time recommended by the manufacturer.Sample/Setting160 wo...

ea0012p94 | Reproduction | SFE2006

Patient satisfaction with the levonorgestrel-releasing intrauterine system

Daud S , Ewies AAA

BackgroundDespite the popularity of levonorgestrel-releasing intrauterine system (LNG-IUS) as a contraceptive and in treating menorrhagia in the UK, patient satisfaction has not been adequately assessed.ObjectivesTo document the patient satisfaction rate with levonorgestrel-releasing intrauterine system (LNG-IUS).Sample160 women who had a LNG-IUS inserted from 1st...

ea0011s54 | Monogenic disorders illuminate metabolic disease | ECE2006

Epidemic obesity in humans

O’Rahilly S

Implicit in the justification for the enormous increase in investment in bio-molecular research that has occurred over the past 20 years has been the promise that this would provide insights relevant to the understanding of human pathophysiology and the ultimate alleviation of suffering from human disease. To this end, model organisms are enormously attractive as they provide tractable and controllable systems in which precise and ‘clean’ data can be obtained. In con...

ea0011s93 | Contrasting practices in European endocrinology | ECE2006

Contrasting practices in European endocrinology. Radioiodine therapy. A Danish view

Hegedüs L

Radioiodine (131-I)- in use for more than 50 years for hyperthyroidism, with or without goitre, and also more recently for non-toxic goitre- has proven effective in the treatment of hyperthyroidism as well as in reducing goitre size. In hyperthyroidism, one or two 131-I doses will cure nearly all patients. Factors such as: sex, age, morphological goitre type, size of goitre, presence of thyroid autoantibodies, and pre- and post-radioiodine antithyroid drug (ATD) therapy influe...

ea0011p55 | Clinical case reports | ECE2006

Screening of osteoporosis in a small Romanian town

Mandasescu S , Trisca MM

Introduction: In the last decade, after the revolution in December 1989, osteoporosis started to be seen as an important problem for the women in Romania too. This screening that last three years is trying to find the prevalence of osteoporosis and how is she influenced by different factors as: age, body mass index, smoke, coffee, and years from menopause.Method: We have investigated 440 caucasian women with age between 30 and 80 years old divided in thr...